Allgens Medical Technology Co. Ltd. (688613.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Medical - Devices
Employees
271
First IPO Date
May 21, 2021
| Name | Title | Pay | Year Born |
| Ling Wang | Head of Finance | 0 | 1978 |
| Xiaoying Miao | Accounting Supervisor | 0 | N/A |
| Guofeng Tian | Deputy GM & Director | 0 | 1982 |
| Wanlan Huang | Founder, Deputy GM & Director | 0 | 1943 |
| Yongqiang Wu | Chairman of the Board of Supervisors & Human Resource Director | 0 | 1976 |
| Zhiye Qiu | Deputy GM, Secretary of the Board of Directors & Core Technical Personnel | 0 | 1984 |
| Menglong Cui | GM & Director | 0 | 1978 |
| Tianxi Song | Director, Deputy GM & Core Technical Personnel | 0 | 1981 |
| Fuzhai Cui | Founder & Chief Scientist | 0 | 1945 |
Allgens Medical Technology Co. Ltd. operates as a medical device firm, concentrating on the development and production of sophisticated biomimetic synthetic bone graft systems. These innovative solutions are engineered for global deployment in areas where both cancellous (spongy) and cortical (dense outer layer) bone tissues have been compromised. The company's diverse product portfolio includes key offerings such as BonGold, a mineralized collagen scaffold designed for bone grafting procedures; the high-performance Alligator bone marrow aspirator; and OssaNova, a mineralized collagen-based material utilized for bone filling and augmentation. These products are broadly applied across a spectrum of orthopedic and skeletal repair interventions throughout the human anatomy. Allgens Medical Technology Co. Ltd. was established in 2004 and is headquartered in Beijing, China.